The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
J Vandercappellen, J Van Damme, S Struyf - Cytokine & growth factor …, 2011 - Elsevier
Chemokines are chemotactic cytokines which recruit leukocytes to inflammatory sites. They
also affect tumor development and metastasis by acting as growth factor, by attracting pro-or …
also affect tumor development and metastasis by acting as growth factor, by attracting pro-or …
MALDIquant: a versatile R package for the analysis of mass spectrometry data
MALDIquant is an R package providing a complete and modular analysis pipeline for
quantitative analysis of mass spectrometry data. MALDIquant is specifically designed with …
quantitative analysis of mass spectrometry data. MALDIquant is specifically designed with …
Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview
S Bünger, T Laubert, UJ Roblick… - Journal of cancer research …, 2011 - Springer
Purpose Complete resection constitutes the only curative approach in pancreatic cancer but
is possible only in a minority of patients due to advanced stages upon diagnosis …
is possible only in a minority of patients due to advanced stages upon diagnosis …
Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
Objective Current non-invasive diagnostic tests can distinguish between pancreatic cancer
(pancreatic ductal adenocarcinoma (PDAC)) and chronic pancreatitis (CP) in only about two …
(pancreatic ductal adenocarcinoma (PDAC)) and chronic pancreatitis (CP) in only about two …
A novel serum metabolomics-based diagnostic approach to pancreatic cancer
T Kobayashi, S Nishiumi, A Ikeda, T Yoshie… - … , biomarkers & prevention, 2013 - AACR
Background: To improve the prognosis of patients with pancreatic cancer, more accurate
serum diagnostic methods are required. We used serum metabolomics as a diagnostic …
serum diagnostic methods are required. We used serum metabolomics as a diagnostic …
Aerobic exercise training mitigates tumor growth and cancer-induced splenomegaly through modulation of non-platelet platelet factor 4 expression
Exercise training reduces the incidence of several cancers, but the mechanisms underlying
these effects are not fully understood. Exercise training can affect the spleen function, which …
these effects are not fully understood. Exercise training can affect the spleen function, which …
Serum amino acid profiles and their alterations in colorectal cancer
Mass spectrometry-based serum metabolic profiling is a promising tool to analyse complex
cancer associated metabolic alterations, which may broaden our pathophysiological …
cancer associated metabolic alterations, which may broaden our pathophysiological …
Identification of serum biomarker signatures associated with pancreatic cancer
Pancreatic cancer is an aggressive disease with poor prognosis, due, in part, to the lack of
disease-specific biomarkers that could afford early and accurate diagnosis. With a …
disease-specific biomarkers that could afford early and accurate diagnosis. With a …
Platelet factor 4 as a novel exosome marker in MALDI-MS analysis of exosomes from human serum
Exosomes are nanosized vesicles commonly found in biological fluids as a result of a
secretion process involving endosomes and multivesicular bodies. The isolation and …
secretion process involving endosomes and multivesicular bodies. The isolation and …
Plasma metabolite biomarkers for the detection of pancreatic cancer
Patients with pancreatic cancer (PC) are usually diagnosed at late stages, when the disease
is nearly incurable. Sensitive and specific markers are critical for supporting diagnostic and …
is nearly incurable. Sensitive and specific markers are critical for supporting diagnostic and …